Kymera Therapeutics, Inc. (KYMR)
85.40
+0.47
(+0.55%)
USD |
NASDAQ |
Apr 02, 16:00
85.34
-0.06
(-0.07%)
After-Hours: 20:00
Kymera Therapeutics EPS Diluted (Quarterly) : -0.9674 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Revolution Medicines, Inc. | -1.855 |
| Gilead Sciences, Inc. | 1.742 |
| Regeneron Pharmaceuticals, Inc. | 7.857 |
| Structure Therapeutics, Inc. | 0.56 |
| ACADIA Pharmaceuticals, Inc. | 1.596 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -86.98M |
| Revenue (Quarterly) | 2.87M |
| Total Expenses (Quarterly) | 89.85M |
| Enterprise Value | 6.206B |
| Gross Profit Margin (Quarterly) | 29.20% |
| Profit Margin (Quarterly) | -3.03K% |
| Earnings Yield | -4.31% |
| Normalized Earnings Yield | -4.272 |